The meta-analysis included 14 studies assessing MALAT1 expression and presenting clinical parameters and survival outcomes.<h4>Results</h4>The results illustrated that high MALAT1 expression is predictive of lymph node metastasis (pooled odds ratio [OR] = 2.99, 95% confidence interval [CI] = 1.97-4.54, P < 0.001) and distant metastasis in GC (OR = 3.11, 95% CI = 1.68-5.75, P < 0.001). Here, MALAT1 is linked to gastric cancer.